about
Targeting B cells in atherosclerosis: closing the gap from bench to bedsideHyperlipidemia impairs osteoanabolic effects of PTH.Systems biology of vascular calcificationB lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipidsType-2 innate lymphoid cells control the development of atherosclerosis in miceDeletion of chromosome 9p21 noncoding cardiovascular risk interval in mice alters Smad2 signaling and promotes vascular aneurysm.Myocardin regulates vascular smooth muscle cell inflammatory activation and diseaseHyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro.MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunityHyperlipidemia induces resistance to PTH bone anabolism in mice via oxidized lipids.Phosphate and pyrophosphate mediate PKA-induced vascular cell calcificationT0901317, an LXR agonist, augments PKA-induced vascular cell calcification.Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis.Multiple potential roles for B cells in atherosclerosis.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Regulation of type 1 diabetes development and B-cell activation in nonobese diabetic mice by early life exposure to a diabetogenic environment.Focal high cell density generates a gradient of patterns in self-organizing vascular mesenchymal cells.Nanoscale architecture in atherosclerotic calcification.Calcification is associated with loss of functional calcium-sensing receptor in vascular smooth muscle cells.Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet.Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells.X-Box Binding Protein-1 Dependent Plasma Cell Responses Limit the Development of Atherosclerosis.Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.Regulatory B cell-specific interleukin-10 is dispensable for atherosclerosis development in mice.Sialyltransferase activity and atherosclerosis.BAFF receptor deficiency reduces the development of atherosclerosis in mice--brief report.The Sunlight: A New Immunomodulatory Approach of Atherosclerosis.On the osteogenic expression induced by calcium/phosphate depositionRegulatory mechanisms in vascular calcificationThe role of B cells in atherosclerosisCalcioprotein particles: The LDL of vascular calcification?
P50
Q26828369-2051BE9F-5321-4623-910D-CFED1C73BE66Q33337922-CF9BAD44-1120-485F-97F9-32891E960816Q33669312-4CCC9EED-2E2A-41DB-B0DC-F1EB45425DDBQ33704093-0E7356E3-B635-482D-9C46-17E85AA5A74FQ33784464-4E5EA377-CC54-470E-A988-56696A7A9ACEQ33786641-BD6226C8-EF25-4634-B965-F4402753CB53Q34041869-65C64DBE-9BF1-46D0-BBAB-B0D3E7D97ACBQ35323782-5A88EECA-8A95-459C-A0A7-6567529827FAQ35415040-9F2AADDE-084D-4F0F-ADA4-3CA24A5C2ABCQ35597306-5953C878-F47A-4712-82A8-393977A605F5Q35853986-58C73397-2362-4EB0-9C00-D81707600A07Q36943228-43884659-B218-45FC-B144-87E0DA856D24Q37218460-E01B1EC1-CA4A-49D5-B07A-3DD38F564C88Q38210531-AE1A2EF3-6656-4EEA-A703-91B866461E32Q38210609-3898CFBD-6B21-405A-B00C-9FF5E8C62E74Q38774904-B35A5064-E041-4D99-9A31-0579759240CFQ40096435-8DCB90EC-86A1-4195-AAB9-20BF53AB8984Q42409195-715FF324-14D7-4C49-870B-B5521895D3DBQ42562185-C5C0D779-5B15-45EA-BA6F-D10AE3080C19Q45002024-EF30FFBF-0CAF-4C1F-9FB1-05C483E5B858Q48270888-87F5DF24-DEFD-4454-B063-CFE74B7C704AQ50707613-B261B33C-32BF-4872-8550-EBC26FC862A8Q50941934-EB3AB45D-1128-4857-A6CE-EA99F08CFEF9Q51758326-8E3CFC29-A6A9-4723-8355-EBCD157272A5Q52936101-4380496C-4940-4AC2-9D40-EC3030C17D40Q53062723-F5C4506A-A99A-42DB-8A29-FB019D71977DQ53179275-5F68B47B-F6E3-4E00-92CE-B5EC37C30610Q53589187-80BA88E6-D113-49FC-9A68-AF447E923A39Q62046381-CCDF49BF-46FC-4C36-A80F-6C591C85BECDQ62046431-1493EDEF-6DE8-426E-9DB3-1B2735BD560DQ63916366-15656769-B6FD-4A0A-9E13-D1ECA22F2066Q63916368-04A85970-26F0-4B91-AAE5-08E7043DBDEF
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7255-3497
@en
name
Andrew P Sage
@ast
Andrew P Sage
@en
Andrew P Sage
@es
Andrew P Sage
@nl
type
label
Andrew P Sage
@ast
Andrew P Sage
@en
Andrew P Sage
@es
Andrew P Sage
@nl
prefLabel
Andrew P Sage
@ast
Andrew P Sage
@en
Andrew P Sage
@es
Andrew P Sage
@nl
P106
P1153
35312347000
P21
P31
P496
0000-0001-7255-3497